Title : DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020.

Pub. Date : 2021 Nov

PMID : 34287770






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Both metformin and the sulfonylureas had a significant ROR under condition 2 (3.42 (95% CI 3.01-3.89) and 2.07 (95% CI 1.66-2.57) respectively); however, this association was not present under condition 3 as only confounded cases occurred, and a large majority of reported cases had concurrent exposure to a DPP-4 inhibitor. Metformin dipeptidyl peptidase 4 Homo sapiens